FDA approves Novavax Covid booster for Americans 12 and up
dailymail.co.uk
news
2022-10-19 19:15:34

Published: 15:15 EDT, 19 October 2022 | Updated: 15:16 EDT, 19 October 2022 The FDA has signed off on a third dose of the Novavax COVID-19 vaccine despite waning interest in the jabs among Americans.The agency issued the emergency use authorization for the booster Wednesday, making it the third available to people 12 and older - joining the Pfizer-BioNTech and Moderna shots.It is available to those who are at least six months removed from receiving the two-dose primary series of any of the three jabs.
